Advanced search
Publication Cover
Pharmacogenomics and Personalized Medicine Volume 12, 2019 - Issue
Submit an article Journal homepage
108
Views
4
CrossRef citations to date
0
Altmetric
Original Research

CYP2C19*2 Polymorphism Is Associated with Impaired Oral Clearance of Gliclazide in Healthy Chinese

Elaine Chow1 Phase 1 Clinical Trial Centre, The Chinese University of Hong Kong, Hong Kong;2 Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong KongCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4147-3387
ORCID Icon,
Emily WM Poon2 Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong
,
Benny SP Fok1 Phase 1 Clinical Trial Centre, The Chinese University of Hong Kong, Hong Kong
,
Juliana CN Chan2 Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong KongORCID Iconhttps://orcid.org/0000-0003-1325-1194
ORCID Icon &
Brian Tomlinson1 Phase 1 Clinical Trial Centre, The Chinese University of Hong Kong, Hong Kong;2 Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong;3 Faculty of Medicine, Macau University of Science & Technology, Taipa, MacauORCID Iconhttps://orcid.org/0000-0001-6717-5444
ORCID Icon
Pages 397-401 | Published online: 03 Jan 2020

References

  • Oida T, Yoshida K, Kagemoto A, Sekine Y, Higashijima T. The metabolism of gliclazide in man. Xenobiotica. 1985;15(1):87–96. doi:10.3109/004982585090453383984386
  • Lalau JD, Arnouts P, Sharif A, De Broe ME. Metformin and other antidiabetic agents in renal failure patients. Kidney Int. 2015;87(2):308–322. doi:10.1038/ki.2014.1924599253
  • Yang X, So WY, Ma RC, et al. Use of sulphonylurea and cancer in type 2 diabetes-the Hong Kong Diabetes registry. Diabetes Res Clin Pract. 2010;90(3):343–351. doi:10.1016/j.diabres.2010.08.02220889221
  • Tan B, Zhang YF, Chen XY, Zhao XH, Li GX, Zhong DF. The effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in Chinese subjects. Eur J Clin Pharmacol. 2010;66(2):145–151. doi:10.1007/s00228-009-0736-219847408
  • Yin OQ, Tomlinson B, Chow MS. CYP2C9, but not CYP2C19, polymorphisms affect the pharmacokinetics and pharmacodynamics of glyburide in Chinese subjects. Clin Pharmacol Ther. 2005;78(4):370–377. doi:10.1016/j.clpt.2005.06.00616198656
  • Niemi M, Cascorbi I, Timm R, Kroemer HK, Neuvonen PJ, Kivisto KT. Glyburide and glimepiride pharmacokinetics in subjects with different CYP2C9 genotypes. Clin Pharmacol Ther. 2002;72(3):326–332. doi:10.1067/mcp.2002.12749512235454
  • Shao H, Ren XM, Liu NF, et al. Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics and pharmacodynamics of gliclazide in healthy Chinese Han volunteers. J Clin Pharm Ther. 2010;35(3):351–360. doi:10.1111/jcp.2010.35.issue-320831536
  • Zhang Y, Si D, Chen X, et al. Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects. Br J Clin Pharmacol. 2007;64(1):67–74. doi:10.1111/bcp.2007.64.issue-117298483
  • DiStefano JK, Watanabe RM. Pharmacogenetics of anti-diabetes drugs. Pharmaceuticals (Basel). 2010;3:2610–2646. doi:10.3390/ph308261020936101
  • Zhou Y, Ingelman-Sundberg M, Lauschke VM. Worldwide distribution of cytochrome P450 alleles: a meta-analysis of population-scale Sequencing Projects. Clin Pharmacol Ther. 2017;102(4):688–700. doi:10.1002/cpt.69028378927
  • Wang Y, Zhao X, Lin J, et al. Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack. JAMA. 2016;316(1):70–78. doi:10.1001/jama.2016.866227348249
  • Zhou K, Donnelly L, Burch L, et al. Loss-of-function CYP2C9 variants improve therapeutic response to sulfonylureas in type 2 diabetes: a go-DARTS study. Clin Pharmacol Ther. 2010;87(1):52–56. doi:10.1038/clpt.2009.17619794412
  • Mendes GD, Moreira LD, Pereira Ados S, et al. A bioequivalence study of gliclazide based on quantification by high-performance liquid chromatography coupled with electrospray tandem mass spectrometry. Int J Clin Pharmacol Ther. 2007;45(3):175–185. doi:10.5414/CPP4517517416113
  • Suzuki K, Yanagawa T, Shibasaki T, Kaniwa N, Hasegawa R, Tohkin M. Effect of CYP2C9 genetic polymorphisms on the efficacy and pharmacokinetics of glimepiride in subjects with type 2 diabetes. Diabetes Res Clin Pract. 2006;72(2):148–154. doi:10.1016/j.diabres.2005.09.01916325295
  • Zeng W, Guo Y, Chen P, Liu Z, Chen D, Han C. CYP2C93 variant is associated with antidiabetes efficacy of gliclazide in Chinese type 2 diabetes patients. J Diabetes Investig. 2016;7:764–768. doi:10.1111/jdi.2016.7.issue-5
  • Holstein A, Plaschke A, Ptak M, et al. Association between CYP2C9 slow metabolizer genotypes and severe hypoglycaemia on medication with sulphonylurea hypoglycaemic agents. Br J Clin Pharmacol. 2005;60(1):103–106. doi:10.1111/bcp.2005.60.issue-115963101
  • Holstein A, Hahn M, Patzer O, Seeringer A, Kovacs P, Stingl J. Impact of clinical factors and CYP2C9 variants for the risk of severe sulfonylurea-induced hypoglycemia. Eur J Clin Pharmacol. 2011;67(5):471–476. doi:10.1007/s00228-010-0976-121213107
  • Gokalp O, Gunes A, Cam H, et al. Mild hypoglycaemic attacks induced by sulphonylureas related to CYP2C9, CYP2C19 and CYP2C8 polymorphisms in routine clinical setting. Eur J Clin Pharmacol. 2011;67(12):1223–1229. doi:10.1007/s00228-011-1078-421691805
  • Dai DP, Xu RA, Hu LM, et al. CYP2C9 polymorphism analysis in Han Chinese populations: building the largest allele frequency database. Pharmacogenomics J. 2014;14(1):85–92. doi:10.1038/tpj.2013.223400009
  • Dobrică EC, Găman MA, Cozma MA, Bratu OG, Pantea Stoian A, Diaconu CC. Polypharmacy in type 2 diabetes mellitus: insights from an internal medicine department. Medicina (Kaunas). 2019;55(8):E436. doi:10.3390/medicina5508043631382651
  • Mizutani T. PM frequencies of major CYPs in Asians and caucasians. Drug Metab Rev. 2003;35(2–3):99–106. doi:10.1081/DMR-12002368112959412

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.